BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7217948)

  • 1. Chemical conversion of anthramycin 11-methyl ether to didehydroanhydroanthramycin and its utilization in studies of the biosynthesis and mechanism of action of anthramycin.
    Malhotra RK; Ostrander JM; Hurley LH; McInnes AG; Smith DG; Walter JA; Wright JL
    J Nat Prod; 1981; 44(1):38-44. PubMed ID: 7217948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proof for the biosynthetic conversion of L-[indole-15N]tryptophan to [10-15N]anthramycin using (13C, 15N) labelling in conjunction with 13C-NMR and mass spectral analysis.
    Ostrander JM; Hurley LH; McInnes AG; Smith DG; Walter JA; Wright JL
    J Antibiot (Tokyo); 1980 Oct; 33(10):1167-71. PubMed ID: 7451368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of binding of pyrrolo(1,4)benzodiazepine antitumour agents to deoxyribonucleic acid--anthramycin and tomaymycin.
    Lown JW; Joshua AV
    Biochem Pharmacol; 1979 Jul; 28(13):2017-26. PubMed ID: 224883
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of properties of the in vitro and cellular anthramycin-DNA adducts and characterization of the reaction of anthramycin with chromatin.
    Reynolds VL; Hurley LH
    Chem Biol Interact; 1982 Nov; 42(2):141-51. PubMed ID: 7151226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the anthramycin-d(ATGCAT)2 adduct from one- and two-dimensional proton NMR experiments in solution.
    Graves DE; Stone MP; Krugh TR
    Biochemistry; 1985 Dec; 24(26):7573-81. PubMed ID: 4092025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthramycin binding to deoxyribonucleic acid-mitomycin C complexes. Evidence for drug-induced deoxyribonucleic acid conformational change and cooperativity in mitomycin C binding.
    Kaplan DJ; Hurley LH
    Biochemistry; 1981 Dec; 20(26):7572-80. PubMed ID: 6798992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reaction of anthramycin with DNA. Proton and carbon nuclear magnetic resonance studies on the structure of the anthramycin-DNA adduct.
    Graves DE; Pattaroni C; Krishnan BS; Ostrander JM; Hurley LH; Krugh TR
    J Biol Chem; 1984 Jul; 259(13):8202-9. PubMed ID: 6736032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthramycin inhibition of restriction endonuclease cleavage and its use as a reversible blocking agent in DNA constructions.
    Sumner W; Bennett GN
    Nucleic Acids Res; 1981 May; 9(9):2105-19. PubMed ID: 6272225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolo[1,4]benzodiazepine antibiotics. Biosynthetic conversion of tyrosine to the C2- and C3-proline moieties of anthramycin, tomaymycin, and sibiromycin.
    Hurley LH; Lasswell WL; Ostrander JM; Parry R
    Biochemistry; 1979 Sep; 18(19):4230-7. PubMed ID: 582801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA binding, induction of unscheduled DNA synthesis, and excision of anthramycin from DNA in normal and repair-deficient human fibroblasts.
    Hurley LH; Chandler C; Garner TF; Petrusek R; Zimmer SG
    J Biol Chem; 1979 Feb; 254(3):605-8. PubMed ID: 762084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on substances with antiblastic activity. LIX - Anthramycin and analogs. VIII : synthesis of derivatives of 4H-pyrrolo/1,2-a/[1,5]benzodiazepine].
    Chimenti F; Vomero S; Giuliano R; Artico TM
    Farmaco Sci; 1977 May; 32(5):339-47. PubMed ID: 862889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo stability of anthramycin-DNA conjugate and its potential application as an anthramycin prodrug.
    Hurley LH; Allen CS; Feola JM; Lubawy WC
    Cancer Res; 1979 Aug; 39(8):3134-40. PubMed ID: 455297
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on substances with antiblastic activity. IX. Anthramycin and analogs. IX. Synthesis of 7-methoxy-8-hydroxy-10,11-dihydro-5H-pyrrolo[2,1-c] [1,4] benzodiazepine and other compounds related to oxotomaymycin].
    Scalzo M; Artico M; Giuliano R; Chimenti F; Vomero S; Nacci V
    Farmaco Sci; 1977 Aug; 32(8):579-92. PubMed ID: 891911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaction of anthramycin with DNA. Biological consequences of DNA damage in normal and xeroderma pigmentosum cell.
    Petrusek RL; Uhlenhopp EL; Duteau N; Hurley LH
    J Biol Chem; 1982 Jun; 257(11):6207-16. PubMed ID: 7076670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of DNA sequence specificity of anthramycin and tomaymycin with reaction kinetics and bending of DNA.
    Kizu R; Draves PH; Hurley LH
    Biochemistry; 1993 Aug; 32(33):8712-22. PubMed ID: 8357813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of the DNA helix stabilizing anthramycin-N2 guanine adduct by UVRABC nuclease.
    Walter RB; Pierce J; Case R; Tang MS
    J Mol Biol; 1988 Oct; 203(4):939-47. PubMed ID: 3210245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR analysis of an oligodeoxyribonucleotide-drug adduct: anthramycin-d(ATGCAT).
    Graves DE; Stone MP; Krugh TR
    Prog Clin Biol Res; 1985; 172B():193-205. PubMed ID: 3991708
    [No Abstract]   [Full Text] [Related]  

  • 18. Proposed structure of the anthramycin-DNA adduct.
    Hurley LH; Petrusek R
    Nature; 1979 Nov; 282(5738):529-31. PubMed ID: 503235
    [No Abstract]   [Full Text] [Related]  

  • 19. Porothramycin, a new antibiotic of the anthramycin group: production, isolation, structure and biological activity.
    Tsunakawa M; Kamei H; Konishi M; Miyaki T; Oki T; Kawaguchi H
    J Antibiot (Tokyo); 1988 Oct; 41(10):1366-73. PubMed ID: 3192492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-dimensional NMR studies on the anthramycin-d(ATGCAT)2 adduct.
    Krugh TR; Graves DE; Stone MP
    Biochemistry; 1989 Dec; 28(26):9988-94. PubMed ID: 2620069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.